Towards Safety and Regulation Criteria for Clinical Applications of Decellularized Organ-Derived Matrices
Open Access
- 30 January 2025
- journal article
- review article
- Published by MDPI AG in Bioengineering
- Vol. 12 (2) , 136
Abstract
Whole-organ decellularization generates scaffolds containing native extracellular matrix (ECM) components with preserved tissue microarchitecture, providing a promising advancement in tissue engineering and regenerative medicine. Decellularization retains the ECM integrity which is important for supporting cell attachment, growth, differentiation, and biological function. Although there are consensus guidelines to standardize decellularization processes and ECM characterization, no specific criteria or standards regarding matrix sterility and biosafety have been established so far. This regulatory gap in safety, sterilization, and regulation criteria has hampered the clinical translation of decellularized scaffolds. In this review, we identify essential criteria for the safe clinical use of decellularized products from both human and animal sources. These include the decellularization efficacy, levels of chemical residue, preservation of ECM composition and physical characteristics, and criteria for the aseptic processing of decellularization to assure sterility. Furthermore, we explore key considerations for advancing decellularized scaffolds into clinical practice, focusing on regulatory frameworks and safety requirements. Addressing these challenges is crucial for minimizing risks of adverse reactions or infection transmission, thereby accelerating the adoption of tissue-engineered products. This review aims to provide a foundation for establishing robust guidelines, supporting the safe and effective integration of decellularized scaffolds into regenerative medicine applications.Keywords
Funding Information
- TKI-LSH (Topconsortium Kennis en Innovatie-Life Sciences and Health) (RELOAD, EMC-LSH19002)
This publication has 148 references indexed in Scilit:
- Advances in xenogeneic donor decellularized organs: A review on studies with sheep and porcine‐derived heart valvesBioengineering & Translational Medicine, 2024
- Rapid Volumetric Bioprinting of Decellularized Extracellular Matrix BioinksAdvanced Materials, 2024
- Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor MythClinical Pharmacology & Therapeutics, 2020
- Comparative assessment of the efficiency of various decellularization agents for bone tissue engineeringJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2020
- Biocompatibility and hemocompatibility of efficiently decellularized whole porcine kidney for tissue engineeringJournal of Biomedical Materials Research Part A, 2018
- Effects of antigen removal on a porcine osteochondral xenograft for articular cartilage repairJournal of Biomedical Materials Research Part A, 2018
- Evaluation of genipin for stabilization of decellularized porcine cartilageJournal of Orthopaedic Research, 2016
- The use of whole organ decellularization for the generation of a vascularized liver organoidHepatology, 2010
- Inactivation of bacterial spores and viruses in biological material using supercritical carbon dioxide with sterilantJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2009
- Alterations of human acellular tissue matrix by gamma irradiation: Histology, biomechanical property, stability, in vitro cell repopulation, and remodelingJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2007